Indications
Neoadjuvant treatment of adult patients with locally advanced fully resectable melanoma
Composition
- Active substance
- bifikafusp alfa, onfekafusp alfa
- International name (INN)
- bifikafusp alfa;onfekafusp alfa
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Nidlegy
- Active substance
- bifikafusp alfa, onfekafusp alfa
- ATC code
- L01XY
- Therapeutic area
- Melanoma
- Marketing authorisation holder
- Philogen S.p.A.
- Status
- Application withdrawn